Katie Wright's profile photo

Katie Wright

London

Editorial Assistant at EMJ- European Medical Journal

Articles

  • 1 week ago | emjreviews.com | Katie Wright

    A LARGE retrospective cohort study has revealed a significant decline in the surgical overtreatment of low-risk prostate cancer over the past two decades. By analysing data from 185,928 male patients across two registries, Surveillance, Epidemiology, and End Results (SEER) and the Michigan Urological Surgery Improvement Collaborative (MUSIC), researchers found a more than fivefold reduction in the number of prostatectomies resulting in pathologic grade group 1 (pGG1) diagnoses from 2010 to 2024.

  • 1 week ago | emjreviews.com | Katie Wright

    A BLOOD test identifying nine specific microRNAs has been found to distinguish adolescents with depression from their healthy peers, offering a promising new biomarker for early detection and intervention in teenage depression. Adolescent depression is a growing public health concern, often leading to chronic symptoms, poor treatment response, and lifelong mental health challenges.

  • 1 week ago | emjreviews.com | Katie Wright

    FLU vaccination prevented up to 120,000 hospital admissions in England during the 2024/25 season, despite concerning declines in uptake among some vulnerable groups, UK Health Security Agency (UKHSA) reports. The UKHSA analysed national flu data for the 2024/25 winter season, marked by high influenza activity and pressure on NHS services. Using routine surveillance and vaccine effectiveness modelling, the agency estimated that the flu vaccine averted between 96,000 and 120,200 hospitalisations.

  • 1 week ago | emjreviews.com | Katie Wright

    A LARGE-SCALE study of over 2,500 toddlers has found no significant early-age clinical differences between males and females with autism spectrum disorder (ASD), suggesting that sex differences in autistic traits may emerge later in development rather than at the time of first diagnosis. Understanding whether boys and girls with autism present with different symptoms at the earliest stages of life is crucial for early identification, intervention, and tailoring support.

  • 1 week ago | emjreviews.com | Katie Wright

    SEVERE ASTHMA is a complex and burdensome condition, often resistant to conventional therapies. Biologics targeting type 2 (T2) inflammation have transformed treatment, improving symptoms and reducing exacerbations. Tezepelumab, a monoclonal antibody targeting thymic stromal lymphopoietin (TSLP), offers broader T2 suppression and is unique in being licensed for use regardless of T2 biomarker levels.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →